References
La Puma J. Physician rewards for postmarketing surveillance (seeding studies) in the US. PharmacoEconomics 1995; 7 (3): 187–90
Members ofthe ASCPT Pharmacoepidemiology Section. Notes of the American Society for Clinical Pharmacology and Therapeutics: position paper on the use of purported postmarketing drug surveillance studies for promotional purposes. Clin Pharmacol Ther 1990; 48: 598
Jefferys DB, Jones KH. EMEA and the new pharmaceutical procedures for Europe. Eur J Clin Pharmacol 1995; 47: 471–6
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Soto, J., Sacristan, J.A. Should the Philosophy of Postmarketing Surveillance in the US be Redefined?. Pharmacoeconomics 8, 175–176 (1995). https://doi.org/10.2165/00019053-199508020-00009
Published:
Issue Date:
DOI: https://doi.org/10.2165/00019053-199508020-00009